569 related articles for article (PubMed ID: 26373570)
1. Obesity and cancer: mechanistic insights from transdisciplinary studies.
Allott EH; Hursting SD
Endocr Relat Cancer; 2015 Dec; 22(6):R365-86. PubMed ID: 26373570
[TBL] [Abstract][Full Text] [Related]
2. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.
Colditz GA
J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
4. Dietary fat and chronic diseases: epidemiologic overview.
Kuller LH
J Am Diet Assoc; 1997 Jul; 97(7 Suppl):S9-15. PubMed ID: 9216562
[TBL] [Abstract][Full Text] [Related]
5. Obesity and prostate cancer: weighing the evidence.
Allott EH; Masko EM; Freedland SJ
Eur Urol; 2013 May; 63(5):800-9. PubMed ID: 23219374
[TBL] [Abstract][Full Text] [Related]
6. Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions.
Ligibel JA; Strickler HD
Am Soc Clin Oncol Educ Book; 2013; ():52-9. PubMed ID: 23714455
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trials.
Benjamin DJ; Haslam A; Prasad V
Cancer Med; 2024 Mar; 13(5):e7049. PubMed ID: 38491813
[TBL] [Abstract][Full Text] [Related]
8. Feeding the critically ill obese patient: a systematic review protocol.
Secombe P; Harley S; Chapman M; Aromataris E
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
[TBL] [Abstract][Full Text] [Related]
9. Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies.
Bens A; Langballe R; Bernstein JL; Cronin-Fenton D; Friis S; Mellemkjaer L
Acta Oncol; 2019 Nov; 58(11):1581-1593. PubMed ID: 31393200
[No Abstract] [Full Text] [Related]
10. Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods.
Moyad MA
Asian J Androl; 2015; 17(6):874-7; discussion 876. PubMed ID: 26112486
[TBL] [Abstract][Full Text] [Related]
11. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
Picon-Ruiz M; Morata-Tarifa C; Valle-Goffin JJ; Friedman ER; Slingerland JM
CA Cancer J Clin; 2017 Sep; 67(5):378-397. PubMed ID: 28763097
[TBL] [Abstract][Full Text] [Related]
12. Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective.
Moyad MA
Urology; 2002 Apr; 59(4 Suppl 1):41-50. PubMed ID: 11937435
[TBL] [Abstract][Full Text] [Related]
13. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
Goodwin PJ; Stambolic V
Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
[TBL] [Abstract][Full Text] [Related]
14. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry.
Jonsson F; Wolk A; Pedersen NL; Lichtenstein P; Terry P; Ahlbom A; Feychting M
Int J Cancer; 2003 Sep; 106(4):594-599. PubMed ID: 12845658
[TBL] [Abstract][Full Text] [Related]
15. Statin use and cancer risk: a comprehensive review.
Boudreau DM; Yu O; Johnson J
Expert Opin Drug Saf; 2010 Jul; 9(4):603-21. PubMed ID: 20377474
[TBL] [Abstract][Full Text] [Related]
16. Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality.
Koo HY; Jeong SM; Cho MH; Chun S; Shin DW; Park J
Sci Rep; 2021 Aug; 11(1):16171. PubMed ID: 34373584
[TBL] [Abstract][Full Text] [Related]
17. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
Haukka J; Niskanen L; Auvinen A
Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
[TBL] [Abstract][Full Text] [Related]
18. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618901
[TBL] [Abstract][Full Text] [Related]
19. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
Gronich N; Rennert G
Nat Rev Clin Oncol; 2013 Nov; 10(11):625-42. PubMed ID: 24080598
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
Vona-Davis L; Rose DP
Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
